If you’ve ever ordered a vial of purified protein for a lab experiment, a batch of freeze-dried biopharmaceutical ingredient, or even a reagent for industrial food processing, you probably didn’t think about the long chain of steps that got that product to your doorstep. For me, as a downstream processing supplier, that chain is my entire focus. My team designs and builds the equipment that takes raw biological or chemical feedstocks—think cell culture broths, fermentation outputs, or crude chemical extracts—and turns them into pure, usable products. But no matter how clever our equipment is, no matter how tight our quality controls, if the label on that final product doesn’t meet global regulations, none of it matters. That’s the truth we live and breathe every day at my company: downstream processing isn’t just about purification. It’s about making sure the product that leaves our facility is not only pure, but also compliant, safe, and clearly communicated to whoever uses it. Let’s break down what labeling requirements for products after downstream processing actually mean, why they’re non-negotiable, and how we help our clients navigate the messy, often conflicting rules that govern this space. Downstream Processing
First, it’s important to define what “products after downstream processing” actually refers to, because the rules change dramatically depending on what that product is. Downstream processing (DSP) is the series of steps that follow upstream processing—like cell growth or fermentation—to isolate, purify, and finish the target molecule or material. For biopharmaceutical clients, that could be a monoclonal antibody (mAb) for cancer treatment, a vaccine antigen, or a protein for enzyme replacement therapy. For industrial clients, it might be a food additive, a cosmetic ingredient, or a specialty chemical used in manufacturing. Each of these products falls under a different regulatory umbrella, and that means their labeling requirements are entirely separate. For example, a mAb intended for injection into a patient isn’t the same as a protein used to clear food waste in a production line, so their labels can’t be either.
Let’s start with the most heavily regulated category: biopharmaceuticals. If a product is going to be used in human or animal medicine, regulatory bodies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan have extremely specific rules. Back in 2021, I worked with a small biotech startup out of Boston that was preparing to run clinical trials for a new COVID-19 oral enzyme therapy. They’d finished purification on our ÄKTA-style chromatography system, and their batches were ready for formulation. But when they reached out to me, panicking, they realized their draft labels were missing a critical requirement: a unique identifier for each batch, linked to traceability through every step of DSP. The FDA’s 2019 Drug Supply Chain Security Act (DSCSA) requires that all prescription drugs have a 2D barcode on every package, with a unique serial number, lot number, expiration date, and product name. If that barcode is missing, or if the lot number on the label doesn’t match the batch record from our DSP equipment, the biotech can’t ship the product to trial sites. We ended up modifying our in-line labeling tool for their final packaging step to auto-populate that barcode from our system, so there was zero human error in matching the label to the batch data. That moment drove home something I see too often: many DSP-focused clients are great at purification, but terrible at translating that technical work into regulatory-compliant labels. That’s why we’ve built a whole support service around this part of the process now.
For biopharma products, the labeling requirements don’t stop at barcodes. There are also content requirements that vary by region. In the U.S., prescription drug labels need to include the established name of the drug, the strength, the dosage form, the route of administration, the lot number, expiration date, manufacturer name and address, and storage conditions. In the EU, on top of all that, labels must also include “batch release data” that confirms the product meets all quality specifications set by the EMA—something we’re required to flag to our clients before a batch is released, because if the release data isn’t on the label, the batch is considered invalid. Even something as simple as storage conditions can be a trap for new clients. Last year, a Canadian biotech working on a gene therapy vector labeled their final product “store at -20°C” after DSP, but their clinical trial protocol required “store at -80°C.” The EMA rejected their labeling because it didn’t match the approved drug master file (DMF), and they had to re-package every batch, costing them six weeks of trial time. That’s the kind of mistake that makes our job as a DSP supplier harder, but also more valuable: we don’t just sell equipment. We review labels with our clients before they finalize batches, flagging discrepancies between their technical specs and regulatory rules.
Now, if we move away from biopharmaceuticals to the next largest category of DSP products: food and food ingredients. The rules here are set by bodies like the U.S. Food Safety and Inspection Service (FSIS) and the EU’s European Food Safety Authority (EFSA), and they’re just as strict, but often more focused on transparency for consumers. For example, if a dairy processor uses our membrane filtration system to purify whey protein for use in protein bars, the label on that purified whey can’t just say “whey protein”—it has to list its origin (cow milk), any processing aids used during DSP (like enzymes or filter aids), and allergen information, even if the allergen is removed during purification. Wait, that’s a key point: even if a DSP step removes lactose or casein from whey, if the processing line was shared with milk products, the label still has to note a potential cross-contamination risk, because EFSA requires that. We had a client in Germany last year that made plant-based meat products, and their purified pea protein had a tiny trace of soy from a shared DSP processing line. They wanted to omit soy from the label, thinking the DSP had removed all traces, but EFSA’s 2020 allergen labeling update requires that any potential cross-contact from shared equipment during DSP must be disclosed, even if it’s below the limit of detection. That’s a rule that’s easy to miss when you’re deep in the technical side of purification. We now include a pre-labeling audit as a standard part of our food-grade DSP system delivery, because skipping that step leads to rejected batches at customs or retail shelves—something no food processor can afford, especially with tight margins.
The third big category of DSP products is industrial materials: specialty chemicals, cosmetic ingredients, and agricultural inputs like plant growth regulators. These are often less heavily regulated than biopharma or food, but that doesn’t mean labeling requirements are loose. For example, in the U.S., the Occupational Safety and Health Administration (OSHA)’s Hazard Communication Standard (HazCom) requires that all chemical products have a Global Harmonized System (GHS) label, with hazard symbols, signal words, hazard statements, and precautionary statements. If a client is using our solvent extraction DSP system to purify a specialty chemical for use in cleaning products, the label on the final drum can’t just say “specialty solvent”—it has to note that it’s flammable, irritates skin, and requires personal protective equipment when handling. I remember a small chemical manufacturing startup in Ohio that used our DSP system to purify a new plasticizer. They forgot that the GHS label requires the product’s Chemical Abstracts Service (CAS) number, which is a unique identifier for the chemical. Without that number, OSHA fines can run into thousands of dollars per batch, even if there’s no safety issue with the product. We added a tool to our DSP control software that auto-generates the correct GHS label for industrial chemical products, pulling the CAS number and hazard data from a global database, so our clients don’t have to look it up themselves. That’s been a game-changer for clients who don’t have a dedicated regulatory team.
But here’s the thing that makes labeling requirements for DSP products so complicated: rules aren’t global. A product that’s compliant for sale in the U.S. might not be compliant in Australia, Brazil, or South Korea. For example, the EU’s REACH (Registration, Evaluation, Authorization, and Restriction of Chemicals) regulation requires that every chemical product sold in the EU has a unique registration number, which has to be on the label. A client that sells a personal care ingredient purified on our DSP system to the EU has to have that registration number, otherwise they can’t ship it. I worked with a U.S. cosmetic ingredient maker last year that was shipping to the EU, and their labels didn’t have the REACH number, because they’d thought it was just an internal document for the supplier. We had to help them navigate the REACH registration process, which took three months, and during that time, they lost a major contract with a European beauty brand. That’s why we now have a network of regulatory consultants on call, specializing in different regions, to help our clients with cross-border labeling compliance. We don’t just sell equipment—we’re a resource for navigating the global regulatory maze.
Another often-overlooked part of DSP product labeling is batch traceability. When you’re dealing with products that could be dangerous if something goes wrong (think a toxic chemical or a contaminated vaccine), regulators need to be able to trace every batch back to its original feedstock, every step of DSP, every operator, and every piece of equipment used. That means the label on the final product has to have enough lot and batch information to make that traceability possible. For biopharma products, the FDA’s DSCSA and EMA’s Falsified Medicines Directive (FMD) require that lot numbers are linked to every step of DSP, so if a batch is recalled, regulators can quickly find every unit that was shipped. For food products, FSIS requires that the lot number on the label can be traced back to the raw milk or grain, so if there’s a salmonella outbreak, processors can isolate the exact source. We’ve designed our DSP control systems to log every detail of a batch—when it was processed, which column or filter was used, which operator ran it, what the purity level was—and then generate a QR code or barcode on the final label that links directly to that batch data. That means if a client needs to do a recall, they don’t have to spend days digging through paper records; they can scan the label and have every detail in seconds.
I think a lot of people outside our industry see downstream processing as just the “dirty work” of turning raw materials into something usable. But from where I stand, it’s the most important step between a raw feedstock and a safe, compliant product. The labeling requirements aren’t just red tape—they’re there to protect patients, consumers, workers, and the environment. And as a DSP supplier, our job is to make those requirements as easy as possible for our clients to meet. We’ve seen too many small biotechs, food processors, and chemical startups fail because they got so focused on perfecting their purification process that they forgot about labeling. That’s why we invest so much time in understanding the latest regulations across every region and product category, and building tools and support to help our clients comply.
If you’re a lab manager at a biotech, a quality control lead at a food processor, or a product development manager at a chemical company, and you’re working on a downstream processing project—whether you’re purifying a new drug, a food ingredient, or an industrial material—don’t let labeling requirements derail your work. We’ve helped hundreds of clients across industries navigate these rules, from the initial design of their DSP system all the way through to final labeling and batch release. We can help you audit your draft labels for compliance, adjust your DSP equipment to auto-generate regulatory-approved labels, or connect you with our network of regional regulatory experts to make cross-border sales easy. For too long, DSP suppliers have focused only on purification efficiency, but we think it’s time to put compliance at the center of what we do. The product that leaves your facility shouldn’t just be pure—it should be ready to sell, safe to use, and fully compliant with every rule that applies to it.
If you have questions about labeling requirements for your specific DSP product, or you’d like to learn how we can support your next project, reach out to our team to schedule a consultation. We’re here to help you get it right, on time, and without the regulatory headaches.
Tangential Flow Filtration System References
- U.S. Food and Drug Administration. (2019). Drug Supply Chain Security Act (DSCSA) Final Rule.
- European Medicines Agency. (2020). Falsified Medicines Directive (FMD) Labeling Requirements for Human Medicinal Products.
- U.S. Food Safety and Inspection Service. (2022). Food Allergen Labeling and Consumer Protection Act (FALCPA) Updated Guidelines.
- European Food Safety Authority. (2020). Cross-Contamination Allergen Labeling Requirements for Processed Food Ingredients.
- Occupational Safety and Health Administration. (2023). Hazard Communication Standard (HazCom) 2012 Update on GHS Labeling.
- European Chemicals Agency. (2021). REACH Regulation Labeling and Registration Requirements for Industrial Chemicals.
Hangzhou Guidling Technology Co., Ltd.
Address: No.795, 18th Street, Qiantang New District, Hangzhou City, Zhejiang Province, China
E-mail: export1@guidling.net
WebSite: https://www.guidlingfiltration.com/
